Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study

Rui Wang; Changming Zhao; Shuxia Jiang; Zhaohua Zhang; Chunmei Ban; Guiping Zheng; Yan Hou; Bingjin Jin; Yannan Shi; Xin Wu; Qiangqiang Zhao

doi:10.3389/fbioe.2022.1027868

Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study

Front Bioeng Biotechnol. 2022 Oct 10:10:1027868. doi: 10.3389/fbioe.2022.1027868. eCollection 2022.

Authors

Rui Wang¹, Changming Zhao¹, Shuxia Jiang², Zhaohua Zhang², Chunmei Ban³, Guiping Zheng², Yan Hou², Bingjin Jin⁴, Yannan Shi⁵, Xin Wu⁶, Qiangqiang Zhao²

Affiliations

¹ Department of Hematology, Shandong Second Provincial General Hospital, Jinan, China.
² Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
³ Department of Hematology, Hematology Department, The People's Hospital of Liuzhou City, Liuzhou, China.
⁴ Department of Pharmacy, The Qinghai Provincial People's Hospital, Xining, China.
⁵ Department of General Medicine, Ganmei Hospital, Kunming First People's Hospital, Kunming, China.
⁶ Department of Spine Surgery, Third Xiangya Hospital, Central South University, Changsha, China.

Abstract

With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging topics related to leukemia research. 1825 Articles and reviews were obtained from the WoSCC and analyzed by Citespace and Vosviewer. INTERNATIONAL JOURNAL OF NANOMEDICINE is the journal with the highest output. The contribution of FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY is also noteworthy. The three main aspects of research in Nanoparticles-leukemia-related fields included nanoparticles for the diagnosis and treatment of leukemia, related to the type and treatment of leukemia, the specific molecular mechanism, and existing problems of the application of nanoparticles in leukemia. In the future, synthesize nano-drugs that have targeted therapy and chemotherapy resistance according to the mechanism, which may be the dawn of the solution to leukemia. This study offers a comprehensive overview of the Nanoparticles-leukemia-related field using bibliometrics and visual methods for the first time, providing a valuable reference for researchers interested in Nanoparticles-leukemia.

Keywords: chemotherapy; drug resistance; leukemia; nanoparticles; target therapy.